# The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea

> **NCT02714400** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 20 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Venlafaxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02714400
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714400, "The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02714400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*